Authors:
Monali Tayade, Sampada Kulkarni
Download free PDF
Enteral Feeding Devices Market Size & Share 2026-2035
Report ID: GMI745
|
Published Date: October 2026
|
Report Format: PDF/Excel/Dashboard/Platform
Explore Our Licensing Options:
Enteral Feeding Devices Market
Get a free sample of this report
What are you hoping to find?
Your PDF is on its way. Tell us little about your research goal, and we'll help you find the most relevant market insights.
Enteral Feeding Devices Market Size
The Enteral Feeding Devices Market was valued at USD 6.50 billion in 2025, is expected to reach USD 6.86 billion in 2026, is projected to expand at a 5.5% CAGR (2026–2035), and is forecast to reach USD 11.10 billion by 2035. The market comprises devices used to deliver nutrition, fluids, and medications into the gastrointestinal tract when oral intake is not possible or clinically sufficient, including tubes and catheters, pumps, administration sets, syringes, connectors, and accessories.
Enteral Feeding Devices Market Key Takeaways
Market Leader: Fresenius Kabi led with over 11.5% market share in 2025.
Leading Players: Top 5 players in this market include Fresenius Kabi, Avanos Medical, B. Braun, Becton Dickinson, Cardinal Health, which collectively held a market share of 43.5% in 2025.
Demand is being reshaped by an older patient population, longer survival with neurological and oncological conditions, and a shift from episodic inpatient treatment toward managed nutrition across long-term and home-based settings. Product mix is consequently moving beyond basic access devices toward recurring consumables, safety-oriented connection systems, and ambulatory platforms that can support continuity of care.
GMI Analyst View
Our discussions with industry experts indicate that the global enteral feeding devices market maintained a compound growth rate of 6.4% from 2022 to 2025, driven by accelerated post-pandemic restoration of elective clinical nutrition programs, ENFit connector transition procurement, and above-trend growth in home enteral nutrition enrollment across North America and Europe. This above-plan historic trajectory underpins the structural momentum entering the 2026–2035 forecast period.
Enteral Feeding Devices Market Trends, Growth Drivers & GMI Forecast Outlook
The outlook rests on persistent clinical need rather than discretionary consumption. Aging, nutrition-screening protocols, and connector replacement cycles support recurring demand, while reimbursement discipline and uneven provider capacity determine how much clinically indicated care converts into realized device revenue across care settings.
Key Drivers
Evidence anchors use cited external data; demand implications and forecast conditions represent GMI analysis.
Aging raises demand not only through patient count, but through the duration and complexity of nutritional support. Stroke, progressive neurological disease, cancer treatment, and frailty can convert a short inpatient nutrition intervention into a sustained requirement for gastrostomy access, administration sets, and caregiver-supported feeding. This creates a recurring replacement base for providers that maintain patients across hospital discharge and post-acute care.
Acute-care demand has a different purchasing logic. Hospitals must keep feeding pumps, sets, and access products available for critically ill patients even when admissions fluctuate, because nutrition protocols are embedded in care pathways rather than elective procurement. The clinical emphasis on reducing interruptions to prescribed nutrition also favors devices with reliable delivery, alarm management, and compatible consumables.
ENFit adoption adds a compliance-led replacement layer to underlying patient demand. As health systems retire legacy connections, the conversion affects tubes, extension sets, syringes, and giving sets together. Manufacturers with broad compatible portfolios can therefore participate in both the initial conversion and subsequent replenishment cycle, while providers seek to reduce training and inventory complexity.
Key Restraints
Evidence anchors use cited external data; demand implications and forecast conditions represent GMI analysis.
Reimbursement scrutiny can weaken the commercial infrastructure needed to deliver home enteral therapy. Documentation requirements, medical-necessity review, and constrained payment structures raise the operating burden for suppliers, particularly where they must coordinate equipment, disposables, training, and clinical support. The resulting margin pressure can make patient acquisition and service coverage less attractive even where clinical need remains intact.
Supplier consolidation and exits can translate directly into access limitations. The National Home Infusion Association describes provider concern over the economics of home enteral services, including the prospect of withdrawing from the category in some cases [5]National Home Infusion Association. "Trends in Home Enteral Nutrition." nhia.org. Where service networks narrow, eligible patients may experience slower discharge coordination, fewer local options, or greater reliance on institutional settings.
Tube-placement safety also limits how quickly programs can scale. Misplacement, obstruction, aspiration risk, and the need for verification protocols require trained staff and dependable clinical processes [2]Karayeva, A. et al. / BMC Nursing. "Knowledge, Attitude, and Practice of Nurses Regarding Enteral Feeding: A Systematic Review." bmcnursing.biomedcentral.com. Large hospitals can absorb these requirements through specialized nutrition teams, whereas lower-resource facilities may prioritize simpler products or defer broader program expansion.
GMI Analyst View
We see the market separating into two demand pools: recurring clinical consumption that remains resilient, and technology-led procurement that must clear a higher economic hurdle. Suppliers that document fewer feeding interruptions, smoother transitions across care settings, and lower caregiver burden should be better positioned where provider budgets remain constrained.
Enteral Feeding Devices Market Segment Analysis
By Product
Enteral Feeding Tubes & Catheters Enteral feeding tubes and catheters generated USD 2.47 billion in 2025 and are expected to advance at a 4.9% CAGR (2026–2035). The Enteral Feeding Devices Market depends on this category as the foundational patient-access layer across acute, long-term, and home-based care. Demand reflects the need for both short-term nasogastric access and durable gastrostomy solutions, while product differentiation increasingly centers on material performance, placement support, and standardized connection compatibility.
Administration / Giving Sets Administration and giving sets accounted for approximately 18.0% of the market in 2025 and are forecast to grow at a 5.1% CAGR (2026–2035). Their recurring use makes them central to the market's replenishment economics. ENFit conversion reinforces this demand by requiring providers to align tubing, extension components, and feeding protocols within a compatible system rather than treating each disposable item as a stand-alone purchase.
Enteral Syringes (Bolus) Enteral syringes are forecast to generate USD 999 million by 2035 and held a 10.0% share in 2025. Bolus administration remains relevant for patients whose feeding regimens can be managed outside continuous pump delivery, particularly in home and long-term care. The category's clinical role is closely tied to caregiver education and safety-focused syringe selection, as providers work to minimize misconnections and support reliable medication and nutrition administration.
Connectors & Accessories Connectors and accessories generated USD 390 million in 2025 and are anticipated to expand at an 8.0% CAGR (2026–2035). This growth reflects replacement demand created by standardized connector adoption and the wider use of extension sets, retention products, clamps, and other supporting components. Suppliers can deepen institutional relationships through these smaller but clinically necessary items, especially when they are specified alongside access devices or pumps.
By End Use
Hospital Hospitals generated USD 3.58 billion in 2025 and are projected to grow at a 4.7% CAGR (2026–2035). They remain the most dependable purchasing environment for the Enteral Feeding Devices Market because nutrition support is integrated into intensive care, surgical, oncology, and general medical pathways. Procurement increasingly favors systems that support protocol adherence, product standardization, and dependable supply availability across high-acuity departments.
Long-term Care / Nursing Homes Long-term care and nursing homes are expected to reach USD 2.40 billion by 2035 and grow at a 5.3% CAGR (2026–2035). This setting serves patients with persistent dysphagia, neurodegenerative conditions, and other long-duration nutritional needs. Facility purchasing is consequently shaped by replacement frequency, staff familiarity, maintenance requirements, and the value of stable supply agreements for ongoing tube and administration-set use.
Home Care Home care held a 23.0% share in 2025 and is set to advance at a 7.4% CAGR (2026–2035). It is the most commercially attractive setting for portable and connected feeding platforms because it moves nutritional support closer to the patient while creating a need for simplified operation and remote oversight. However, the pace at which home care converts into device revenue remains dependent on reimbursement structures and the availability of capable local suppliers.
GMI Analyst View
We believe product competition will increasingly be decided by how effectively suppliers connect recurring consumables with a credible care-delivery proposition. Basic access products preserve volume, but pumps, connectors, and home-oriented systems offer the clearest route to differentiation when they reduce workflow friction for clinicians and caregivers.
Enteral Feeding Devices Market Regional Analysis
North America Enteral Feeding Devices Market Analysis
North America generated USD 2.47 billion in 2025 and is forecast to reach USD 3.91 billion by 2035. The Enteral Feeding Devices Market in the region is supported by mature clinical nutrition infrastructure, established hospital purchasing systems, and broad familiarity with home enteral therapy. Growth is increasingly driven by demographic demand, care-setting transitions, and equipment upgrades rather than by first-time program formation.
U.S
The U.S. market is projected to reach USD 3.48 billion by 2035 and grow at a 4.6% CAGR (2026–2035). Its scale reflects a deep network of acute-care hospitals, skilled nursing settings, and home-enteral service providers. Adoption of advanced placement support and ambulatory pump systems is strongest where providers can link device use to safety, discharge management, and continuity of nutrition support.
Canada
Canada accounted for approximately 4.0% of the global market in 2025 and is forecast to expand at a 5.2% CAGR (2026–2035). Provincial care models and hospital-community coordination provide a stable foundation for enteral nutrition access. Continuing connector conversion and growing long-term care demand create room for procurement growth, particularly where publicly funded services support transitions out of hospital care.
Europe Enteral Feeding Devices Market Analysis
Europe is expected to reach USD 2.75 billion by 2035 and advance at a 5.0% CAGR (2026–2035). The region combines mature nutrition guidelines, aging populations, and varied reimbursement systems. Commercial opportunity differs by country because hospital financing, home-care coverage, procurement centralization, and the maturity of ENFit implementation are not uniform.
Germany
Germany represented approximately 5.7% of the global market in 2025 and is projected to grow at a 4.7% CAGR (2026–2035). Its established clinical nutrition services and well-developed hospital base sustain demand for high-quality access, pump, and administration products. Market development is more likely to come from technology renewal and chronic-care needs than from major increases in baseline penetration.
United Kingdom
The United Kingdom market is projected to reach USD 490 million by 2035 and grow at a 4.9% CAGR (2026–2035). Coordinated clinical pathways and structured community nutrition support strengthen the role of enteral therapy beyond the acute setting. A mature safety-standardization environment makes supplier execution, service quality, and compatibility with existing procurement structures important competitive factors.
France
France accounted for approximately 3.9% of the global market in 2025 and is forecast to expand at a 4.8% CAGR (2026–2035). Hospital and long-term care demand is reinforced by the country's aging population and established clinical nutrition practice. The development of home-based support pathways remains important to converting patient need into recurring out-of-hospital device use.
Italy
Italy is expected to reach USD 280 million by 2035 and grow at a 5.2% CAGR (2026–2035). Demand is supported by national health-system coverage for home enteral nutrition and a rising burden of conditions requiring prolonged nutritional support. The market offers scope for suppliers that can serve unevenly developed regional home-care infrastructure while maintaining dependable hospital supply.
Asia Pacific Enteral Feeding Devices Market Analysis
Asia Pacific held approximately 28.0% of the global market in 2025 and is forecast to grow at a 6.7% CAGR (2026–2035). The Enteral Feeding Devices Market across the region is defined by wide variation in clinical maturity: advanced markets emphasize technology upgrades and care efficiency, while emerging markets are building nutrition protocols, hospital capacity, and distribution infrastructure that can broaden access.
China
China generated USD 780 million in 2025 and is expected to advance at a 7.5% CAGR (2026–2035). A large hospital base and expanding clinical focus on nutrition support create substantial volume potential across acute and post-acute care. The country also represents a significant future conversion opportunity as standardized connector availability and provider adoption broaden through distributor and hospital networks.
Japan
Japan is projected to reach USD 594 million by 2035 and grow at a 4.3% CAGR (2026–2035). Its mature enteral nutrition practice and established long-term care infrastructure provide a stable demand base. Future value creation is more likely to depend on improved pump functionality, workflow support, and replacement demand than on rapid expansion in the treated patient base.
India
India accounted for approximately 4.0% of the global market in 2025 and is forecast to grow at an 8.2% CAGR (2026–2035). Hospital expansion, increasing clinical recognition of nutrition support, and a developing home-care sector are expanding demand from a comparatively lower penetration base. Suppliers must balance premium product requirements in major hospitals with the need for cost-effective, scalable solutions in a price-sensitive environment.
South Korea
South Korea is projected to hold a 2.6% share of the global market by 2035 and grow at a 5.8% CAGR (2026–2035). Comprehensive insurance coverage and sophisticated hospital care provide a structured purchasing foundation. Demand is supported by broader use of enteral support in rehabilitation and geriatric settings, while home-care expansion and connector standardization offer additional avenues for category development.
Latin America Enteral Feeding Devices Market Analysis
Latin America is forecast to reach USD 571 million by 2035 and expand at a 5.8% CAGR (2026–2035). Growth is anchored in public-hospital procurement, improving clinical nutrition awareness, and greater capacity for managing chronic and complex conditions. Limited home-care reimbursement remains a constraint, making hospital tenders and distributor execution especially influential in shaping demand.
Brazil
Brazil generated USD 146 million in 2025 and is expected to grow at a 6.2% CAGR (2026–2035). Public-sector purchasing provides an important demand base, while private hospital networks create openings for higher-value feeding and placement solutions. Growth in clinical nutrition teams is supporting more consistent device utilization in institutions able to formalize nutrition-support protocols.
Mexico
Mexico is projected to reach USD 136 million by 2035 and grow at a 5.3% CAGR (2026–2035). Expansion in public and private hospital capacity supports demand for core enteral products. Early-stage adoption of international connector and nutrition-management practices may create incremental demand, although procurement remains sensitive to institutional budgets and regional access disparities.
Middle East & Africa Enteral Feeding Devices Market Analysis
Middle East & Africa accounted for approximately 3.0% of the global market in 2025 and is forecast to grow at a 7.0% CAGR (2026–2035). The region's growth opportunity is tied to new hospital capacity, expanding intensive-care capability, and wider establishment of clinical nutrition programs. The pace of progress remains linked to health-investment cycles, local service capacity, and access to trained care teams.
Saudi Arabia
Saudi Arabia represented approximately 0.8% of global market revenue in 2025 and is expected to grow at a 7.5% CAGR (2026–2035). Healthcare investment and the development of clinical nutrition services are broadening procurement needs across public and private hospital systems. Demand is likely to favor suppliers able to support compliant supply chains, staff education, and dependable product availability.
UAE
The UAE market is projected to reach USD 83 million by 2035 and expand at a 7.8% CAGR (2026–2035). High-acuity hospital care, internationally oriented provider networks, and alignment with global medical-device standards support adoption of premium enteral technologies. The country's role as a regional reference market also makes it attractive for companies introducing connected pumps and standardized accessory systems.
South Africa
South Africa generated USD 29 million in 2025 and is forecast to grow at a 6.2% CAGR (2026–2035). Private hospital groups and academic centers anchor current demand, particularly for established access and feeding products. Public-sector procurement remains cost-conscious, creating a market in which durable supply relationships and competitively positioned consumables are important.
GMI Analyst View
We expect regional performance to depend less on patient need than on the operational maturity of nutrition-support systems. Mature markets reward suppliers that improve efficiency and continuity, while developing markets offer longer-run volume potential when investment in hospital capacity, training, and home-care infrastructure translates into routine clinical practice.
Enteral Feeding Devices Market Share & Competitive Landscape
The global enteral feeding devices market exhibits a moderately concentrated competitive structure, with Fresenius Kabi, Avanos Medical, B. Braun, Cardinal Health, and Abbott Laboratories collectively accounting for approximately 43.5% of total market revenue in 2025. Competition in the market is driven by product portfolio breadth, clinical reliability, regulatory compliance, manufacturing quality, distribution reach, and the ability to provide integrated solutions across enteral feeding pumps, feeding tubes, administration sets, and accessories. Established manufacturers benefit from longstanding hospital relationships, established home-care channels, and comprehensive nutrition support portfolios, while competitive differentiation increasingly depends on patient safety features, interoperability, and supply-chain reliability.
Competition outside the leading group remains active across specialized access products, ambulatory pump platforms, neonatal applications, distributor-led markets, and cost-sensitive tenders. Abbott, Baxter, Boston Scientific, Cook Medical, MOOG, VYGON, CONMED, DANONE, AMSINO, ALCOR SCIENTIFIC, and AMT can each influence category competition through product specialization, channel reach, and targeted clinical positioning. As connector standardization progresses, compatibility, clinician training, and supply continuity are becoming as consequential as unit pricing.
Recent Industry Developments
In February 2025, Cardinal Health announced the international expansion of its Kangaroo OMNI enteral feeding pump across Europe, Australia, and New Zealand, with further Asia Pacific and Latin American availability planned [6]Cardinal Health. "Cardinal Health's Kangaroo OMNI™ Enteral Feeding Pump to Launch in New International Markets in 2025." cardinalhealth.co.uk. The rollout extends a connected feeding platform beyond its earlier North American introduction and reflects the growing importance of portable, continuity-of-care products designed for use across hospital and home settings.
In September 2025, Avanos Medical acquires Nexus Medical Avanos Medical completed its acquisition of Nexus Medical, adding the TKO anti-reflux needleless connector technology to its Specialty Nutrition Systems business [7]Avanos Medical. "Avanos Medical Acquires Nexus Medical to Strengthen Nutrition and Medication Delivery in Critical Care." avanos.com. Although the acquired connector is used in nutrition and medication delivery rather than as an enteral connector, the transaction broadens Avanos's critical-care technology portfolio and signals continued interest in acuity-spanning clinical delivery solutions.
Need a specific section of this report?
Purchase regional analysis, country-level analysis, company profiles, or any other segment-level insights separately
based on your research needs.
Frequently Asked Questions (FAQs):
Research methodology, data sources & validation process
This report draws on a structured research process built around direct industry conversations, proprietary modelling, and rigorous cross-validation and not just desk research.
Our 6-step research process
1. Research design & analyst oversight
At GMI, our research methodology is built on a foundation of human expertise, rigorous validation, and complete transparency. Every insight, trend analysis, and forecast in our reports is developed by experienced analysts who understand the nuances of your market.
Our approach integrates extensive primary research through direct engagement with industry participants and experts, complemented by comprehensive secondary research from verified global sources. We apply quantified impact analysis to deliver dependable forecasts, while maintaining complete traceability from original data sources to final insights.
2. Primary research
Primary research forms the backbone of our methodology, contributing nearly 80% to overall insights. It involves direct engagement with industry participants to ensure accuracy and depth in analysis. Our structured interview program covers regional and global markets, with inputs from C-suite executives, directors, and subject matter experts. These interactions provide strategic, operational, and technical perspectives, enabling well-rounded insights and reliable market forecasts.
3. Data mining & market analysis
Data mining is a key part of our research process, contributing nearly 20% to the overall methodology. It involves analysing market structure, identifying industry trends, and assessing macroeconomic factors through revenue share analysis of major players. Relevant data is collected from both paid and unpaid sources to build a reliable database. This information is then integrated to support primary research and market sizing, with validation from key stakeholders such as distributors, manufacturers, and associations.
4. Market sizing
Our market sizing is built on a bottom-up approach, starting with company revenue data gathered directly through primary interviews, alongside production volume figures from manufacturers and installation or deployment statistics. These inputs are then pieced together across regional markets to arrive at a global estimate that stays grounded in actual industry activity.
5. Forecast model & key assumptions
Every forecast includes explicit documentation of:
✓ Key growth drivers and their assumed impact
✓ Restraining factors and mitigation scenarios
✓ Regulatory assumptions and policy change risk
✓ Technology adoption curve parameter
✓ Macroeconomic assumptions (GDP growth, inflation, currency)
✓ Competitive dynamics and market entry/exit expectations
6. Validation & quality assurance
The final stages involve human validation, where domain experts manually review filtered data to identify nuances and contextual errors that automated systems might miss. This expert review adds a critical layer of quality assurance, ensuring data aligns with research objectives and domain-specific standards.
Our triple-layer validation process ensures maximum data reliability:
✓ Statistical Validation
✓ Expert Validation
✓ Market Reality Check
Trust & credibility
Verified data sources
Trade publications
Industry journals, trade publications, and specialized media.
Industry databases
Proprietary and third-party market databases
Regulatory filings
Government procurement records and policy documents
Academic research
University studies and specialist institution reports
Company reports
Annual reports, investor presentations, and filings
Expert interviews
C-suite, procurement leads, and technical specialists
GMI archive
13,000+ published studies across 20+ industry verticals
Trade data
Import/export volumes, HS codes, and customs records
Parameters studied & evaluated
Every data point in this report is validated through primary interviews, true bottom-up modelling, and rigorous cross-checks. Read about our research process →